Incredible Growth Of Respiratory Inhalers Market 2026 Growing With Major Eminent Key Players
Chronic
respiratory diseases are the group of chronic diseases which affect
airways, lungs and the other parts of respiratory system. Chronic
respiratory disease include asthma and respiratory allergies, Chronic
Obstructive Pulmonary Disease (COPD), Occupational Lung Diseases,
Sleep Apnea Syndrome and Pulmonary Hypertension. However 70% chronic
respiratory disease are asthma and chronic obstructive pulmonary
disease. In 2012, globally, 1 billion people are affected with
chronic respiratory disease and account for 7% of all global deaths
with addition 1.4 million lung cancer deaths annually. Tuberculosis
is considered as one of the communicable lung disease and in 2012,
1.3 million people died of tuberculosis and 8.6 million new cases
were yet to be treated.
The
respiratory inhalers market is expected to gain steady traction in
the foreseeable future as the product is available in various designs
and can be used by any age group individual. Manufacturers are
focused on reducing production costs and increasing profitability to
sustain the market demand.
Request
For Sample Copy Of This Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/227
Market
Dynamics
Factors
such as rising prevalence of asthma, chronic obstructive respiratory
disease and other respiratory diseases propel the respiratory
inhalers market globally. However, drawbacks such as lack of a single
effective inhaler devices, adverse effects and difficulties faced
during drug inhalation, lack of skilled pulmonologist, higher price
of inhaler devices are factors hindering respiratory inhalers market
growth.
People
suffering from respiratory disorders are now switching towards
combinational therapies which is associated with benefits such as
increased efficacy and easy reimbursement policies. Opting for
combination therapies becomes tough for the individuals who have
complex indications of respiratory disease. High preference of
combination therapies such as triple combination therapy for chronic
obstructive pulmonary disease (COPD) patients is expected to drive
growth of the global respiratory inhaler market over the forecast
period.
Detailed
Segmentation:
-
Global Respiratory Inhalers Market, By Product Type:
-
Dry Powder Inhalers
-
Single Unit Dose
-
Multi Dose
-
Multi-Unit Dose
-
-
Metered Dose Inhalers
-
Nebulizers
-
Compressed
-
Mesh
-
Ultrasonic
-
-
Growth
in respiratory inhalers market on the backdrop of product launches
and Technological Advancements
For
instance:
-
In 2017, Cipla launched Synchrobreathe, a revolutionary inhaler that will bring great relief to millions of South Africans with obstructive airway diseases (OAD) such as asthma
-
Smart inhalers have embedded sensors with bluetooth technology. These devices also come up with touchscreens, audio visual medication reminders along with additional advantages such as mobile application connectivity, customized user interface options, real time analysis through cloud based portals through researchers and clinicians. In September, 2017, Adherium received approval from the U.S Food and Drug Administration (FDA) for its SmartTouch inhaler monitoring device to be used with AstraZeneca’s Symbiocort aerosol inhaler.
-
In October, 2017, United Therapeutics Corporation received U.S. FDA approval for a new inhalation device TD-300/A, for the use with Tyvaso (treprostinil) inhalation solution to treat patient with pulmonary arterial hypertension. The device aid patient compliance and provides ease of use. It will also reduce the rate of therapy discontinuation associated with the current nebulizer.
Increasing
number of research collaborations is expected to improve the
time-to-market of highly effective and advanced products. Some of the
major players involved in global respiratory inhalers market are
AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH,
Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck &
Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding and
Teva Pharmaceutical Industries Ltd.
Click
To Read More On Respiratory
Inhalers Market
About
Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Comments
Post a Comment